Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 143 entries
View as:

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00303459 Org: User:
Start: 05/31/06 End: 12/31/13 Due: 12/31/14

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program

Phase: N/A Priority: Normal
NCT ID: NCT01389206 Org: User:
Start: 06/01/11 End: 04/10/18 Due: 04/10/19

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma

Phase: N/A Priority: Normal
NCT ID: NCT00077584 Org: User:
Start: 10/31/03 End: 05/31/05 Due: 05/31/06

Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00319046 Org: User:
Start: 02/01/06 End: 07/01/10 Due: 07/01/11

Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01223352 Org: User:
Start: 03/08/11 End: 08/19/13 Due: 08/19/14

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Phase: N/A Priority: Normal
NCT ID: NCT00317486 Org: User:
Start: 09/30/03 End: 04/30/05 Due: 04/30/06

Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01499251 Org: User:
Start: 01/31/12 End: 04/30/16 Due: 04/30/17

Digital Ulceration

Phase: N/A Priority: Normal
NCT ID: NCT01377090 Org: User:
Start: 01/31/11 End: 08/31/12 Due: 08/31/13

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01474109 Org: User:
Start: 12/31/11 End: 11/30/13 Due: 11/30/14

Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02223832 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

Miglustat in Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00742092 Org: User:
Start: 08/31/08 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Phase: N/A Priority: Normal
NCT ID: NCT00091715 Org: User:
Start: 04/30/04 End: 02/28/11 Due: 02/28/12

A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT04271475 Org: User:
Start: 07/07/20 End: 12/21/23 Due: 12/21/24

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01739400 Org: User:
Start: 09/10/13 End: 01/12/18 Due: 01/12/19

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00723554 Org: User:
Start: 07/31/08 End: 04/30/11 Due: 04/30/12

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Phase: N/A Priority: Normal
NCT ID: NCT00370214 Org: User:
Start: 03/31/06 End: 12/31/12 Due: 12/31/13

A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Phase: N/A Priority: Normal
NCT ID: NCT03809650 Org: User:
Start: 01/08/19 End: 06/29/20 Due: 06/29/21

Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02791815 Org: User:
Start: 07/31/16 End: 09/30/16 Due: 09/30/17

A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03496506 Org: User:
Start: 03/05/18 End: 05/18/18 Due: 05/18/19

Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03359291 Org: User:
Start: 11/03/17 End: 12/04/17 Due: 12/04/18

A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03215966 Org: User:
Start: 08/07/17 End: 09/24/17 Due: 09/24/18

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Phase: N/A Priority: Normal
NCT ID: NCT05179876 Org: User:
Start: 05/04/22 End: 09/28/29 Due: 09/28/30

Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01346930 Org: User:
Start: 07/31/11 End: 08/31/16 Due: 08/31/17

Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02309463 Org: User:
Start: 01/31/15 End: 02/28/17 Due: 02/28/18

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT04175600 Org: User:
Start: 01/16/20 End: 10/01/27 Due: 10/01/28